Studies have reported that broadly neutralizing antibodies (Abs) have immense potential as antiviral therapeutic agents due to their capability to identify highly conserved epitopes seldom mutated in ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This abstract does not include a full text component.
Antibody humanization involves modifying antibodies from non-human sources, such as mice, to decrease their immunogenicity in human applications. While mouse monoclonal antibodies are specific, they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback